Edition:
India

Avenue Therapeutics Inc (ATXI.OQ)

ATXI.OQ on NASDAQ Stock Exchange Capital Market

3.80USD
22 Jan 2018
Change (% chg)

$-0.08 (-2.06%)
Prev Close
$3.88
Open
$3.85
Day's High
$4.03
Day's Low
$3.79
Volume
14,152
Avg. Vol
9,731
52-wk High
$8.56
52-wk Low
$3.40

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.296
Jun '17 0.00 -0.288
Mar '17 0.00 -0.079
FY 2016 Dec '16 0.00 -0.098
Sep '16 0.00 -0.065
Jun '16 0.00 -0.092
Mar '16 0.00 -0.126
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.10 32.90
P/E High - Last 5 Yrs. -- 40.98 46.03
P/E Low - Last 5 Yrs. -- 23.80 24.39
Beta -- 0.90 0.89
Price to Sales (TTM) -- 3.98 5.45
Price to Book (MRQ) 2.07 4.82 5.38
Price to Tangible Book (MRQ) 2.07 5.57 6.89
Price to Cash Flow (TTM) -- 23.02 23.43
% Owned Institutions 0.28 1.23 2.16

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.51
Dividend 5 Year Growth Rate -- 4.35 5.23
Payout Ratio(TTM) -- 45.67 43.58

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 3.59 9.01
Sales (TTM) vs TTM 1 Yr. Ago -- 4.69 5.44
Sales - 5 Yr. Growth Rate -- 10.10 10.34
EPS (MRQ) vs Qtr. 1 Yr. Ago -212.06 16.23 19.33
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 9.86 10.77
Capital Spending - 5 Yr. Growth Rate -- 15.30 15.26

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.18
Current Ratio (MRQ) 4.85 2.88 2.97
LT Debt to Equity (MRQ) 1.45 9.81 12.10
Total Debt to Equity (MRQ) 23.49 13.80 16.38
Interest Coverage (TTM) -- 36.25 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.13 54.76
Gross Margin - 5 Yr. Avg. -- 52.41 52.45
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.54 15.33
Operating Margin (TTM) -- 14.40 7.60
Operating Margin - 5 Yr. Avg. -- 14.46 10.79
Pre-Tax Margin (TTM) -- 14.82 8.38
Pre-Tax Margin - 5 Yr. Avg. -- 14.77 11.19
Net Profit Margin (TTM) -- 11.09 4.70
Net Profit Margin - 5 Yr. Avg. -- 11.11 7.50
Effective Tax Rate (TTM) -- 23.16 23.05
Effective Tax Rate - 5 Yr. Avg. -- 23.40 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 948,195,516 855,725,045
Net Income/Employee (TTM) -- 111,561,295 100,665,187
Receivable Turnover (TTM) -- 5.61 5.76
Inventory Turnover (TTM) -- 2.57 3.34
Asset Turnover (TTM) -- 0.95 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.41 10.97
Return on Assets - 5 Yr. Avg. -- 12.98 12.39
Return on Investment (TTM) -- 14.84 14.40
Return on Investment - 5 Yr. Avg. -- 16.97 16.20
Return on Equity (TTM) -- 16.32 16.09
Return on Equity - 5 Yr. Avg. -- 18.05 17.53
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 39.21 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Avenue Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 1.37%
# of Holders: 10
Total Shares Held: 140,363
3 Mo. Net Change: 0
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 0
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.